Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

VERNALIS PLC (VER)

3
Delayed Quote. Delayed London Stock Exchange - 04/21 06:44:28 am
46.125 GBp   +1.37%
04/07 VERNALIS : In Drug Discovery Collaboration With Japan's Taisho
04/07 VERNALIS : enters into research collaboration
04/07 VERNALIS : Enters Into Research Collaboration With Taisho Pharmaceut..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/15/2015 04/16/2015 04/17/2015 04/20/2015 04/21/2015 Date
45.75(c) 46.25(c) 44.875(c) 45.5(c) 46.125 Last
2 834 186 11 251 42 842 6 364 13 706 Volume
-1.61% +1.09% -2.97% +1.39% +1.37% Change
More quotes
Financials ( GBP)
Sales 2015 18,3 M
EBIT 2015 -15,8 M
Net income 2015 -12,3 M
Debt 2015 13,5 M
Yield 2015 -
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016 -
Capi. / Sales 2015 11,8x
Capi. / Sales 2016 -
Capitalization 201 M
More Financials
Company
Vernalis Plc is a research and development stage pharmaceutical company.The company provides pharmaceutical products for a range of medical disorders.It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.The group has one marketed product,... 
More about the company
Surperformance© ratings of Vernalis plc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERNALIS PLC
04/07 VERNALIS : In Drug Discovery Collaboration With Japan's Taisho
04/07 VERNALIS : enters into research collaboration
04/07 VERNALIS : Enters Into Research Collaboration With Taisho Pharmaceutical Co., Lt..
03/06 VERNALIS : Gets GBP500,000 Milestone Payment From Asahi Collaboration
03/06 VERNALIS : and AKP Achieve Research Milestone
03/06 VERNALIS : and Asahi Kasei Pharma Achieve Research Milestone
02/26 VERNALIS : licenses proprietary adenosine receptor antagonist technology, includ..
02/26 VERNALIS : Enters Licence Deal With US-Based Biotechnology Firm
More news
Sector news : Biotechnology & Medical Research - NEC
06:34aDJEUROPE MARKETS : European Stocks Pare Gains After German Data; Greek Worries Hov..
06:01a UNITED THERAPEUTICS : To Announce First Quarter 2015 Financial Results Before Ma..
06:01a ALNYLAM PHARMACEUTICALS : Reports 12-Month Clinical Data from Phase 2 Open Label..
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF